Question: Should I be taking an interest in antimicrobial resistance??
"Failure to tackle drug-resistant infections will lead to at least 10 million extra deaths a year and cost the global economy up to $100trillion (£64 trillion) by 2050.”
Jim O'Neill, former Goldman Sachs chief economist, chair of a high-level report commissioned by the UK Government in 2014.
“Antimicrobial resistance poses a catastrophic threat. If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics. And routine operations like hip replacements or organ transplants could be deadly because of the risk of infection.
That’s why governments and organisations across the world, including the World Health Organization and G8, need to take this seriously.
This is not just about government action. We need to encourage more innovation in the development of antibiotics – over the past two decades there has been a discovery void around antibiotics, meaning diseases have evolved faster than the drugs to treat them."
Professor Dame Sally Davies, Chief Medical Officer for England
Come and hear, and have your say, about antimicrobial resistance at this Spotlight on the Longitude Prize event.
What is the Longitude Prize? The Longitude Prize is a global healthcare challenge with a £10m prize fund which aims to conserve antibiotics for future generations and revolutionise the delivery of global healthcare.
The Longitude Prizes challenge researchers across the world to discover a point-of-care diagnostic device hat can rule out antibiotic use or help identify an effective antibiotic to treat a patient; essentially, a cost-effective, accurate, rapid, and easy-to-use test for bacterial infections that will allow health professionals worldwide to administer the right antibiotics at the right time.
It’s a huge challenge that impacts on every one of us.
How can Life Sciences researchers in Scotland and the UK contribute to the discovery?
What are the other challenges we face in dealing with antimicrobial resistance?
Come and find out and have your say at the first Longitude Prize Spotlight event to be hosted in Scotland at the new Discovery Centre for Translational and Interdisciplinary Research.
NESTA SPOTLIGHT ON LONGITUDE PRIZE
WEDNESDAY 28TH JANUARY 2015
5PM DRINKS AND CANAPÉS RECEPTION
6PM – 7:30PM EVENT
DISCOVERY CENTRE FOR TRANSLATIONAL & INTERDISCIPLINARY RESEARCH
Panelists will include:
Professor Mike Ferguson, Regius Professor of Life Sciences and Associate Dean for Research Strategy, University of Dundee
Joshua Ryan-Saha, Assistant Project Manager Longitude Prize, Nesta
Dr Camilla Wiuff, Strategic Lead, Microbiology at Health Protection Scotland
Dr. Miroslav Ravic, Chief Executive Officer, Chief Science Officer & Chief Medical Officer, MGB Biopharma
Dr Till Bachmann, Reader in Personalised Medicine in Infectious Diseases, University of Edinburgh
Professor Andrew Hopkins, Chair of Medicinal Informatics and SULSA Research Professor of Translational Biology, University of Dundee